December 2nd - 4th, 2021


Melanoma Bridge Presidents are glad to invite the submission of abstracts for the presentation of oral communications and posters at next meeting held from December 2nd to December 4th

The themes of oral and poster presentation are:

  • How Covid-19 impacted on our daily practice both clinical and research
  • Melanoma is model for cancer research
  • Emerging strategies
  • Great Debate on:
    • Adoptive cell therapy VS bispecific antibodies in melanoma
    • MAPK inhibition VS immunotherapy on adjuvant setting in melanoma
    • Could corticosteroids used for the management of side effects have an impact on the outcome of melanoma patients: Yes or No?
    • IPI addition to PD-1 backbone VS LAG-3: which one for what patient?
    • Linfo-adenectomy: before or later?
    • Brain metastases: do you need radiation? Yes or No
    • Telemedicine VS face-to-face visit

Attendees are expected from all around the world and encouraged to submit their abstracts for poster or oral presentation during the Melanoma Bridge Congress.

The accepted abstract which have not been published elsewhere will be included in a dedicated Supplement of the Journal of Translational Medicine.

Submission opening: Apr 20th, 2021
Submission deadline: Oct 5th, 2021

Notification: Oct 15th, 2021

Late breaking abstract will not be accepted


Submission Guidelines

Submit your abstract as word file by e-mail to

Receipt of your abstract will be acknowledged by e-mail within a few days. If acknowledgement is not received within one week of submission, please contact us again.

Guidelines for authors

For information please contact